vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and PHINIA INC. (PHIN). Click either name above to swap in a different company.

PHINIA INC. is the larger business by last-quarter revenue ($889.0M vs $749.2M, roughly 1.2× CLOVER HEALTH INVESTMENTS, CORP.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 6.7%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 1.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

PHINIA Inc. is a global automotive technology provider specializing in fuel injection systems, starters, alternators, and hybrid/electric vehicle components. It serves OEMs and aftermarket customers across North America, Europe, Asia Pacific and key markets, covering passenger car, commercial vehicle and industrial mobility segments.

CLOV vs PHIN — Head-to-Head

Bigger by revenue
PHIN
PHIN
1.2× larger
PHIN
$889.0M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+55.3% gap
CLOV
62.0%
6.7%
PHIN
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
1.5%
PHIN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
PHIN
PHIN
Revenue
$749.2M
$889.0M
Net Profit
$27.3M
Gross Margin
21.7%
Operating Margin
3.6%
7.8%
Net Margin
3.6%
Revenue YoY
62.0%
6.7%
Net Profit YoY
EPS (diluted)
$0.05
$1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PHIN
PHIN
Q1 26
$749.2M
Q4 25
$487.7M
$889.0M
Q3 25
$496.6M
$908.0M
Q2 25
$477.6M
$890.0M
Q1 25
$462.3M
$796.0M
Q4 24
$337.0M
$833.0M
Q3 24
$331.0M
$839.0M
Q2 24
$356.3M
$868.0M
Net Profit
CLOV
CLOV
PHIN
PHIN
Q1 26
$27.3M
Q4 25
$-49.3M
Q3 25
$-24.4M
$13.0M
Q2 25
$-10.6M
$46.0M
Q1 25
$-1.3M
$26.0M
Q4 24
$-22.1M
Q3 24
$-9.2M
$31.0M
Q2 24
$7.4M
$14.0M
Gross Margin
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
21.7%
Q3 25
22.0%
Q2 25
22.1%
Q1 25
21.6%
Q4 24
22.7%
Q3 24
24.5%
22.3%
Q2 24
30.3%
21.7%
Operating Margin
CLOV
CLOV
PHIN
PHIN
Q1 26
3.6%
Q4 25
-10.1%
7.8%
Q3 25
-4.9%
3.7%
Q2 25
-2.2%
10.0%
Q1 25
-0.3%
7.8%
Q4 24
-6.4%
6.1%
Q3 24
-2.7%
7.9%
Q2 24
2.0%
8.2%
Net Margin
CLOV
CLOV
PHIN
PHIN
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
1.4%
Q2 25
-2.2%
5.2%
Q1 25
-0.3%
3.3%
Q4 24
-6.6%
Q3 24
-2.8%
3.7%
Q2 24
2.1%
1.6%
EPS (diluted)
CLOV
CLOV
PHIN
PHIN
Q1 26
$0.05
Q4 25
$1.14
Q3 25
$0.33
Q2 25
$1.14
Q1 25
$0.63
Q4 24
$0.13
Q3 24
$0.70
Q2 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PHIN
PHIN
Cash + ST InvestmentsLiquidity on hand
$177.6M
$359.0M
Total DebtLower is stronger
$970.0M
Stockholders' EquityBook value
$339.4M
$1.6B
Total Assets
$697.7M
$3.8B
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PHIN
PHIN
Q1 26
$177.6M
Q4 25
$78.3M
$359.0M
Q3 25
$349.0M
Q2 25
$347.0M
Q1 25
$373.0M
Q4 24
$194.5M
$484.0M
Q3 24
$288.0M
$477.0M
Q2 24
$254.8M
$339.0M
Total Debt
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
$970.0M
Q3 25
$990.0M
Q2 25
$990.0M
Q1 25
$989.0M
Q4 24
$988.0M
Q3 24
$987.0M
Q2 24
$821.0M
Stockholders' Equity
CLOV
CLOV
PHIN
PHIN
Q1 26
$339.4M
Q4 25
$308.7M
$1.6B
Q3 25
$340.9M
$1.6B
Q2 25
$344.2M
$1.6B
Q1 25
$336.1M
$1.5B
Q4 24
$341.1M
$1.6B
Q3 24
$342.2M
$1.7B
Q2 24
$324.9M
$1.7B
Total Assets
CLOV
CLOV
PHIN
PHIN
Q1 26
$697.7M
Q4 25
$541.0M
$3.8B
Q3 25
$559.7M
$4.0B
Q2 25
$575.0M
$3.9B
Q1 25
$583.7M
$3.7B
Q4 24
$580.7M
$3.8B
Q3 24
$653.0M
$4.0B
Q2 24
$674.2M
$3.9B
Debt / Equity
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
0.61×
Q3 25
0.62×
Q2 25
0.61×
Q1 25
0.64×
Q4 24
0.63×
Q3 24
0.58×
Q2 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PHIN
PHIN
Operating Cash FlowLast quarter
$96.0M
Free Cash FlowOCF − Capex
$67.0M
FCF MarginFCF / Revenue
7.5%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$188.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
$-66.9M
$96.0M
Q3 25
$12.1M
$119.0M
Q2 25
$5.4M
$57.0M
Q1 25
$-16.3M
$40.0M
Q4 24
$34.8M
$73.0M
Q3 24
$50.0M
$95.0M
Q2 24
$44.8M
$109.0M
Free Cash Flow
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
$-69.0M
$67.0M
Q3 25
$11.4M
$93.0M
Q2 25
$4.8M
$23.0M
Q1 25
$-16.5M
$5.0M
Q4 24
$33.3M
$53.0M
Q3 24
$49.6M
$70.0M
Q2 24
$44.4M
$92.0M
FCF Margin
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
-14.1%
7.5%
Q3 25
2.3%
10.2%
Q2 25
1.0%
2.6%
Q1 25
-3.6%
0.6%
Q4 24
9.9%
6.4%
Q3 24
15.0%
8.3%
Q2 24
12.5%
10.6%
Capex Intensity
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
0.4%
3.3%
Q3 25
0.1%
2.9%
Q2 25
0.1%
3.8%
Q1 25
0.0%
4.4%
Q4 24
0.5%
2.4%
Q3 24
0.1%
3.0%
Q2 24
0.1%
2.0%
Cash Conversion
CLOV
CLOV
PHIN
PHIN
Q1 26
Q4 25
Q3 25
9.15×
Q2 25
1.24×
Q1 25
1.54×
Q4 24
Q3 24
3.06×
Q2 24
6.04×
7.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PHIN
PHIN

Customer$618.0M70%
Fuel Systems$194.0M22%
Other$77.0M9%

Related Comparisons